New generation capsaicin-diclofenac containing, silicon-based transdermal patch provides prolonged analgesic effect in acute and chronic pain models
New generation combined low-concentration capsaicin-diclofenac containing TTS can be an effective therapeutic tool in acute and chronic pain states involving neuropathic and inflammatory components.
Authors
- Gábor Pozsgai (ORCID: https://orcid.org/0000-0002-8524-7162)
- Szilárd Pál (ORCID: https://orcid.org/0000-0003-4558-0486)
- Lajos Botz (ORCID: https://orcid.org/0000-0003-0407-1247)
- Szabolcs László
- Ágnes Dombi
- Zsófia Hajna (ORCID: https://orcid.org/0009-0009-4421-0150)
- Ödön Wagner
- Erika Pintér (ORCID: https://orcid.org/0000-0001-9898-632X)
- Valéria Tékus (ORCID: https://orcid.org/0000-0003-2918-4475)
- Kitti Göntér (ORCID: https://orcid.org/0009-0006-7022-1724)
- Katalin Fábián
Institutions
- Budapest University of Technology and Economics (HU)
- University of Pecs (HU)
Publication Details
- Journal
- European Journal of Pharmaceutical Sciences
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1016/j.ejps.2025.107035
- Citations
- 5
- Primary Topic
- Pain Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.82
Funders
- Pécsi Tudományegyetem
- Magyarország Kormánya
- Általános Orvostudományi Kar, Pécsi Tudományegyetem